Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
09 déc. 2024 07h25 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™ Magnetic...
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
02 déc. 2024 08h45 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’ latest...
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference
26 nov. 2024 08h28 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
25 nov. 2024 08h21 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced regulatory approval of the...
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
20 nov. 2024 08h18 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2024 Third Quarter Financial Results
11 nov. 2024 16h02 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
06 nov. 2024 08h25 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
23 oct. 2024 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
21 oct. 2024 08h41 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis to Present at Upcoming Investor Conferences
09 sept. 2024 08h40 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...